Irregular PKR activation has been implicated in various diseases, including dystonia, SLE, Alzheimer's disease, and Huntington's disease (Liu et al., 2019; Lee et al., 2020; Kuipers et al., 2021; Reimer et al., 2021). This evidence concerns the gene EIF2AK2 and Dystonia.